Erratum: A global assessment of the oesophageal adenocarcinoma epidemic (Gut (2013) 62 (1406-1414) DOI: 10.1136/gutjnl-2012-302412);A global assessment of the oesophageal adenocarcinoma epidemic

Gut

Volumn 62, Issue 10, 2013, Pages 1406-1414

  Edgren, Gustaf ^a,b   Adami, Hans Olov ^a,b   Vainio, Elisabete Weiderpass ^b,c,d,e   Nyrén, Olof ^b,f  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c CANCER REGISTRY OF NORWAY   (Norway)

^d UNIVERSITY OF TROMSØ   (Norway)

^e FOLKHÄLSAN RESEARCH CENTER   (Finland)

^f VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; EPIDEMIC; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; TREND STUDY; UNITED KINGDOM; UNITED STATES;

EID: 84877689938     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-302412corr1     Document Type: Erratum

References (52)

1. Wang HH, Antonioli DA, Goldman H. Comparative features of esophageal and gastric adenocarcinomas: recent changes in type and frequency. Hum Pathol 1986;17:482-7. (Pubitemid 16061455)
2. Yang PC, Davis S. Epidemiological characteristics of adenocarcinoma of the gastric cardia and distal stomach in the United States, 1973-1982. Int J Epidemiol 1988;17:293-7.
3. Yang PC, Davis S. Incidence of cancer of the esophagus in the US by histologic type. Cancer 1988;61:612-17. (Pubitemid 18039379)
4. Hesketh PJ, Clapp RW, Doos WG, et al. The increasing frequency of adenocarcinoma of the esophagus. Cancer 1989;64:526-30. (Pubitemid 19180418)
5. Powell J, McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 1990;62:440-3. (Pubitemid 20292843)
6. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
7. Trivers KF, Sabatino SA, Stewart SL. Trends in esophageal cancer incidence by histology, United States, 1998-2003. Int J Cancer 2008;123:1422-8.
8. Cook MB, Chow WH, Devesa SS. Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br J Cancer 2009;101:855-9.
9. Lagergren J, Mattsson F. No further increase in the incidence of esophageal adenocarcinoma in Sweden. Int J Cancer 2011;129:513-16.
10. Schmassmann A, Oldendorf MG, Gebbers JO. Changing incidence of gastric and oesophageal cancer subtypes in central Switzerland between 1982 and 2007. Eur J Epidemiol 2009;24:603-9.
11. Bosetti C, Levi F, Ferlay J, et al. Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer 2008;122:1118-29. (Pubitemid 351214012)
12. Steevens J, Botterweck AA, Dirx MJ, et al. Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol 2010;22:669-78.
13. Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008;100:1184-7.
14. National Cancer Institute. Joinpoint Regression Program, Version 3.5 - April 2011. Statistical Methodology and Applications Branch and Data Modeling Branch, Surveillance Research Program National Cancer Institute, 2011.
15. Storm HH, Michelsen EV, Clemmensen IH, et al. The Danish Cancer Registry-history, content, quality and use. Dan Med Bull 1997;44:535-9.
16. Swerdlow AJ. Cancer registration in England and Wales: some aspects relevant to interpretation of the data. J R Stat Soc 1986;149:146-60.
17. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a populationbased cancer registry. Experience in Finland. Acta Oncol 1994;33:365-9. (Pubitemid 24207996)
18. Larsen IK, Småstuen M, Johannesen TB, et al. Data quality at the cancer registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009;45:1218-31.
19. Brewster DH, Crichton J, Harvey JC, et al. Completeness of case ascertainment in a Scottish regional cancer registry for the year 1992. Public Health 1997;111:339-43. (Pubitemid 27412226)
20. Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish cancer register: a sample survey for year 1998. Acta Oncol 2009;48:27-33.
21. Curado MP, Edwards B, Shin HR, et al, eds. Cancer Incidence in Five Continents, Vol. IX. Lyon: IARC Scientific Publications, 2007.
22. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989;8:551-61. (Pubitemid 19116001)
23. Clayton D, Schifflers E. Models for temporal variation in cancer rates. II: age-period-cohort models. Stat Med 1987;6:469-81. (Pubitemid 17110909)
24. Carstensen B. Age-period-cohort models for the Lexis diagram. Stat Med 2007;26:3018-45. (Pubitemid 46939424)
25. Bray F, Carstensen B, Møller H, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev 2005;14:2191-9. (Pubitemid 41603267)
26. Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000;19:335-51. (Pubitemid 30070608)
27. Hansson LE, Sparén P, Nyrén O. Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer 1993;54:402-7. (Pubitemid 23169677)
28. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005;97:142-6. (Pubitemid 40277094)
29. Pohl H, Sirovich B, Welch HG. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol Biomarkers Prev 2010;19:1468-70.
30. Lindblad M, Ye W, Lindgren A, et al. Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann Surg 2006;243:479-85.
31. McColl KE, Going JJ. Aetiology and classification of adenocarcinoma of the gastro-oesophageal junction/cardia. Gut 2010;59:282-4.
32. Vizcaino AP, Moreno V, Lambert R, et al. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer 2002;99:860-8. (Pubitemid 34575705)
33. Nyrén O, Adami HO. Esophageal cancer. In: Adami HO, Hunter D, Trichopoulos D, eds. Textbook of Cancer Epidemiology. New York: Oxford University Press, 2008:196-238.
34. Hvid-Jensen F, Pedersen L, Drewes AM, et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011;365:1375-83.
35. Lagergren J, Bergström R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31. (Pubitemid 29142625)
36. El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 2007;5:17-26. (Pubitemid 46096825)
37. Van Soest EM, Dieleman JP, Siersema PD, et al. Increasing incidence of Barrett's oesophagus in the general population. Gut 2005;54:1062-6. (Pubitemid 41025895)
38. Coleman HG, Bhat S, Murray LJ, et al. Increasing incidence of Barrett's oesophagus: a population-based study. Eur J Epidemiol 2011;26:739-45.
39. O'Doherty MG, Freedman ND, Hollenbeck AR, et al. A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study. Gut. Published Online First: 15 December 2011. doi:10.1136/gutjnl-2011-300551
40. Lagergren J. Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol 2011;8:340-7.
41. WHO Global Database on Body Mass Index. http://apps.who.int/bmi/index.jsp
42. Edgren G, Liang L, Adami HO, et al. Enigmatic sex disparities in cancer incidence. Eur J Epidemiol 2012;27:187-96.
43. Lepage C, Rachet B, Jooste V, et al. Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am J Gastroenterol 2008;103:2694-9.
44. Bhat S, Coleman HG, Yousef F, et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. J Natl Cancer Inst 2011;103:1049-57.
45. De Jonge PJ, Van Blankenstein M, Looman CW, et al. Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study. Gut 2010;59:1030-6.
46. Freedman ND, Derakhshan MH, Abnet CC, et al. Male predominance of upper gastrointestinal adenocarcinoma cannot be explained by differences in tobacco smoking in men versus women. Eur J Cancer 2010;46:2473-8.
47. Cronin-Fenton DP, Murray LJ, Whiteman DC, et al. Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. Eur J Cancer 2010;46:2067-76.
48. Masaka T, Iijima K, Endo H, et al. Gender differences in oesophageal mucosal injury in a reflux oesophagitis model of rats. Gut. Published Online First: 27 January 2012. doi:10.1136/gutjnl-2011-301389
49. Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila) 2008;1:329-38.
50. Banatvala N, Mayo K, Megraud F, et al. The cohort effect and Helicobacter pylori. J Infect Dis 1993;168:219-21. (Pubitemid 23178754)
51. Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 1995;9(Suppl 2):33-9.
52. De Martel C, Parsonnet J. Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys. Dig Dis Sci 2006;51:2292-301.